Intravenous Induction Agents-Propanidid
Eugenol is obtained from the oil of cloves. The derivatives of eugenol were investigated for their anaesthetic properties in the late 1950s. Three compounds were developed; G29.505 (Eunal), E34 (Propinal) and FBA.1420 (Propanidid). G29.505, or 2-methoxy-4-allylphenoxyacetic acid-N: N diethylamide, was studied initially in Europe with promising results. Wright and Payne conducted clinical trials of the drug at the Hammersmith Hospital in Britain and reported a 33% of venous thrombosis. They were impressed by the shortness of action, the respiratory stimulation and the lack of any circulatory disturbances but felt that the venous thrombosis made it unacceptable for routine use. G29.505 was virtually insoluble in water and was presented in an emulsion of lecithin known as gliddophil. It was thought that the thrombosis was due to the solvent, not the drug itself. Since no solution could be found to this problem, this drug was soon abandoned.
Propinal was studied only briefly and found to have similar properties to G29.505. Nishimura reported on its use in 1962 and found it to be a useful adjunct to nitrous oxide anaesthesia. He found a high incidence of postoperative nausea and vomiting if atropine premedication was not used, and noted lymphangitis in some patients.
FBA.1420, or propanidid, was developed separately to G29.505 and has some quite different properties. Propanidid is 3-methoxy-4-(N,N diethyl carbamidomethoxy) phenylacetic acid n-propylester and is inactivated by plasma cholinesterases whereas G29.505 is inactivated by oxidation. FBA.1420 is a yellowish coloured oil and was made into a 5% solution with 20% aqueous solution of polyoxyethylated castor oil (Cremophor EL) which acted as a solubilizing agent.
T. H. Howard and colleagues studied propanidid at the Royal Free Hospital in 1964. They anaesthetized 550 patients with the aim of studying the drug over a wide range of clinical practice. Patients received either 5 mg/kg or 10mg/kg depending on the group they were assigned to and ten patients received an intravenous infusion. Overall they concluded that this was a useful drug but encountered some problems. The induction was followed by a brief period of hyperventilation which then led to a period of respiratory depression. This was more common with the higher dose but the 5 mg/kg group were considered to be inadequately narcotized. They reported a 33% drop in blood pressure over the first minute, which was rapidly corrected. Other side-effects were few; there was no laryngospasm or bronchospasm and a very low incidence of thrombophlebitis. They found no increased incidence of nausea and vomiting and no consistent evidence of analgesic properties. By chance they discovered that propanidid had local anaesthetic properties and began using it to raise a skin wheal prior to the introduction of a Mitchell needle. They discovered that this effect lasted many hours and thought it to be responsible for the lack of pain with extravasation.
In the same year Dundee and Clarke compared propanidid with G29.505, thiopentone and methohexitone. They concluded that propanidid resembled G29.505 in that it was an effective anaesthetic agent with a low incidence of excitatory or respiratory sideeffects. They found that propanidid produced rapid awakening and that the patients were very clear-headed. This was attributed to the fact that the drug is rapidly metabolized and not redistributed like the barbiturates. They also reported a high incidence of nausea and vomiting which they postulated was due to the rapid awakening. They concluded by noting that the incidence of thrombophlebitis was much less with propanidid than G29.505 but that further work needed to be done to compare it with the barbiturates.
A study in Canada by Gordon Wyant and Dale Zoerb concluded that propanidid would only be suitable on rare occasions in their institution. They used the drug for 50 cervical dilations and cautery and for several repeat electroshock therapy patients. They encountered many problems with the surgical patients. "Some of the phenomena, such as breath-holding, moving, phonation, emesis and swallowing may be largely explained by the fact that anaesthesia was intentionally kept light, and a minimum of intravenous anaesthetic was used." They noted that administration of additional propanidid in these circumstances did not always resolve the situation. On three occasions suxamethonium was given to control muscle rigidity and another eighteen patients were problematic due to rigidity. "Coughing and bucking on the airway was noticeable and disturbing in five cases. One patient stated that she 'heard voices' throughout the procedure, but did not feel any discomfort. This had been a very unsatisfactory anaesthetic because of uncontrollable movement, despite a total of 1175 mg of propanidid, and there had been hiccough, rigidity, phonation and swallowing."
Propanidid subsequently found a limited place in anaesthesia. It was used in Britain, Europe and Australia predominantly for minor surgery in outpatients. Both the hypotension and the hypoventilation produced were greater than with thiopentone which meant it had to be used with caution, especially in the elderly. Eventually there were reports of anaphylactic reactions which were attributed to the solvent, Cremophor EL. The incidence was reported to be around 1:500-1:17,000 which was comparable to Althesin. There was one isolated report of a suspected cross sensitivity between propanidid and another drug dissolved in Cremophor EL in a patient who had had a previous uneventful exposure. One case of cardiac arrest was reported in 1970. Studies in healthy volunteers revealed a fourfold increase in histamine levels following propanidid administration.
By the 1980s propanidid was rarely used in the United Kingdom although it was still available in Europe. The introduction of other, safer short-acting drugs such as propofol meant that it ceased to be a useful drug. Propanidid was never approved for use in the United States. CHRISTINE BALL, ROD WESTHORPE Geoffrey Kaye Museum of Anaesthetic History
